{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:41:10Z","timestamp":1776436870952,"version":"3.51.2"},"reference-count":64,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/21\/B\/NZ7\/02747"],"award-info":[{"award-number":["2016\/21\/B\/NZ7\/02747"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/35\/B\/NZ7\/03256"],"award-info":[{"award-number":["2019\/35\/B\/NZ7\/03256"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In particular conditions, inhibition of an immune response is required to prevent tissue damage. Among these conditions are diseases caused by an over-reactive immune response, such as autoimmune or allergic disorders, or imminent organ rejection after transplantation. To avoid tissue damage, drug-mediated systemic immune suppression is an option, but it comes with high costs in the form of susceptibility to viral and bacterial infections. Thus, the induction of antigen-specific tolerance is preferable. Extracellular vesicles (EVs) are capable of delivering antigen together with immunosuppressive signals and may be used to specifically induce antigen-specific tolerance. However, naturally occurring EVs are heterogeneous and not all of them show immunosuppressive character. In our trials to engineer cell culture derived EVs to increase their tolerogenic potential, we equipped them with immunosuppressive miRNA mimics. Small EVs (sEVs) were isolated and purified from the human monocytic THP-1 cell line or from healthy donor peripheral blood mononuclear cells, and electroporated with miR-494 and miR-146a mimics. The acquired immunosuppressive potential of the modified sEVs was demonstrated by their ability to alter the major histocompatibility complex molecules and co-stimulatory receptors present on dendritic cells (DCs). To avoid allogeneic responses, the same cells that produced the sEVs served also as recipient cells. In contrast to the treatment with unmodified sEVs, the tolerogenic sEVs impeded lipopolysaccharide-induced maturation and kept DCs in a more immature developmental stage. Our experiments show that simple manipulations of sEVs using immunosuppressive cargo can lead to the inhibition of DC maturation.<\/jats:p>","DOI":"10.1007\/s00005-022-00664-7","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T06:02:37Z","timestamp":1667282557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Small Extracellular Vesicles Loaded with Immunosuppressive miRNAs Leads to an Inhibition of Dendritic Cell Maturation"],"prefix":"10.2478","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9008-5041","authenticated-orcid":false,"given":"Liliana","family":"Czernek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-0409","authenticated-orcid":false,"given":"\u0141ukasz","family":"P\u0119czek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7869-9577","authenticated-orcid":false,"given":"Markus","family":"D\u00fcchler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"664_CR1","doi-asserted-by":"publisher","first-page":"104063","DOI":"10.1016\/j.cellimm.2020.104063","volume":"349","author":"G Benichou","year":"2020","unstructured":"Benichou G, Wang M, Ahrens K et al (2020) Extracellular vesicles in allograft rejection and tolerance. Cell Immunol 349:104063. https:\/\/doi.org\/10.1016\/j.cellimm.2020.104063","journal-title":"Cell Immunol"},{"key":"664_CR2","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.4049\/jimmunol.1900692","volume":"203","author":"S Biswas","year":"2019","unstructured":"Biswas S, Mandal G, Roy Chowdhury S et al (2019) Exosomes produced by mesenchymal stem cells drive differentiation of myeloid cells into immunosuppressive M2-polarized macrophages in breast cancer. J Immunol 203:3447\u20133460. https:\/\/doi.org\/10.4049\/jimmunol.1900692","journal-title":"J Immunol"},{"key":"664_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00262-010-0954-6","volume":"60","author":"L Castiello","year":"2011","unstructured":"Castiello L, Sabatino M, Jin P et al (2011) Monocyte-derived DC maturation strategies and related pathways: a transcriptional view. Cancer Immunol Immunother 60:457\u2013466. https:\/\/doi.org\/10.1007\/s00262-010-0954-6","journal-title":"Cancer Immunol Immunother"},{"key":"664_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.febslet.2011.01.010","volume":"585","author":"T Chen","year":"2011","unstructured":"Chen T, Li Z, Jing T et al (2011) MicroRNA-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting CD40L in oxLDL-stimulated dendritic cells. FEBS Lett 585:567\u2013573. https:\/\/doi.org\/10.1016\/j.febslet.2011.01.010","journal-title":"FEBS Lett"},{"key":"664_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen G, Huang AC, Zhang W et al (2018) Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560:382\u2013386. https:\/\/doi.org\/10.1038\/s41586-018-0392-8","journal-title":"Nature"},{"key":"664_CR6","doi-asserted-by":"publisher","first-page":"751079","DOI":"10.3389\/fcell.2021.751079","volume":"9","author":"H Chen","year":"2021","unstructured":"Chen H, Wang L, Zeng X et al (2021) Exosomes, a new star for targeted delivery. Front Cell Dev Biol 9:751079. https:\/\/doi.org\/10.3389\/fcell.2021.751079","journal-title":"Front Cell Dev Biol"},{"key":"664_CR7","first-page":"9007","volume":"63","author":"A Cuenca","year":"2003","unstructured":"Cuenca A, Cheng F, Wang H et al (2003) Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens. Cancer Res 63:9007\u20139015","journal-title":"Cancer Res"},{"key":"664_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00005-016-0453-3","volume":"65","author":"L Czernek","year":"2017","unstructured":"Czernek L, D\u00fcchler M (2017) Functions of cancer-derived extracellular vesicles in immunosuppression. Arch Immunol Ther Exp 65:311\u2013323. https:\/\/doi.org\/10.1007\/s00005-016-0453-3","journal-title":"Arch Immunol Ther Exp"},{"key":"664_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/sji.12371","volume":"82","author":"L Czernek","year":"2015","unstructured":"Czernek L, Chworos A, D\u00fcchler M (2015) The uptake of extracellular vesicles is affected by the differentiation status of myeloid cells. Scand J Immunol 82:506\u2013514. https:\/\/doi.org\/10.1111\/sji.12371","journal-title":"Scand J Immunol"},{"key":"664_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/mps4010010","volume":"4","author":"I Dasgupta","year":"2021","unstructured":"Dasgupta I, Chatterjee A (2021) Recent advances in miRNA delivery systems. Methods Protoc 4:10. https:\/\/doi.org\/10.3390\/mps4010010","journal-title":"Methods Protoc"},{"key":"664_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.imlet.2015.05.018","volume":"166","author":"MT de Aquino","year":"2015","unstructured":"de Aquino MT, Malhotra A, Mishra MK et al (2015) Challenges and future perspectives of T cell immunotherapy in cancer. Immunol Lett 166:117\u2013133. https:\/\/doi.org\/10.1016\/j.imlet.2015.05.018","journal-title":"Immunol Lett"},{"key":"664_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/cells8070665","volume":"8","author":"M D\u00fcchler","year":"2019","unstructured":"D\u00fcchler M, Czernek L, Peczek L et al (2019) Melanoma-derived extracellular vesicles bear the potential for the induction of antigen-specific tolerance. Cells 8:665. https:\/\/doi.org\/10.3390\/cells8070665","journal-title":"Cells"},{"key":"664_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fimmu.2013.00438","volume":"4","author":"AM Dudek","year":"2013","unstructured":"Dudek AM, Martin S, Garg AD et al (2013) Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front Immunol 4:438. https:\/\/doi.org\/10.3389\/fimmu.2013.00438","journal-title":"Front Immunol"},{"key":"664_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/cells11010115","volume":"11","author":"M Elashiry","year":"2021","unstructured":"Elashiry M, Elsayed R, Cutler CW (2021) Exogenous and endogenous dendritic cell-derived exosomes: lessons learned for immunotherapy and disease pathogenesis. Cells 11:115. https:\/\/doi.org\/10.3390\/cells11010115","journal-title":"Cells"},{"key":"664_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/vaccines10010133","volume":"10","author":"P Engeroff","year":"2022","unstructured":"Engeroff P, Vogel M (2022) The potential of exosomes in allergy immunotherapy. Vaccines 10:133. https:\/\/doi.org\/10.3390\/vaccines10010133","journal-title":"Vaccines"},{"key":"664_CR16","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/vaccines8040706","volume":"8","author":"C Fu","year":"2020","unstructured":"Fu C, Zhou L, Mi QS et al (2020) DC-based vaccines for cancer immunotherapy. Vaccines 8:706. https:\/\/doi.org\/10.3390\/vaccines8040706","journal-title":"Vaccines"},{"key":"664_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MOT.0000000000000489","volume":"23","author":"B Gonzalez-Nolasco","year":"2018","unstructured":"Gonzalez-Nolasco B, Wang M, Prunevieille A et al (2018) Emerging role of exosomes in allorecognition and allograft rejection. Curr Opin Organ Transplant 23:22\u201327. https:\/\/doi.org\/10.1097\/MOT.0000000000000489","journal-title":"Curr Opin Organ Transplant"},{"key":"664_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/cells8040307","volume":"8","author":"S Gurunathan","year":"2019","unstructured":"Gurunathan S, Kang MH, Jeyaraj M et al (2019a) Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells 8:307. https:\/\/doi.org\/10.3390\/cells8040307","journal-title":"Cells"},{"key":"664_CR19","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.4049\/jimmunol.1900692","volume":"203","author":"S Gurunathan","year":"2019","unstructured":"Gurunathan S, Kang MH, Jeyaraj M et al (2019b) Exosomes produced by mesenchymal stem cells drive differentiation of myeloid cells into immunosuppressive M2-polarized macrophages in breast cancer. J Immunol 203:3447\u20133460. https:\/\/doi.org\/10.4049\/jimmunol.1900692","journal-title":"J Immunol"},{"key":"664_CR20","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/cells8121605","volume":"8","author":"CR Harrell","year":"2013","unstructured":"Harrell CR, Jovicic N, Djonov V et al (2013) Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells 8:1605. https:\/\/doi.org\/10.3390\/cells8121605","journal-title":"Cells"},{"key":"664_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12943-021-01376-w","volume":"20","author":"R Hosseini","year":"2021","unstructured":"Hosseini R, Asef-Kabiri L, Yousefi H et al (2021) The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells. Mol Cancer 20:83. https:\/\/doi.org\/10.1186\/s12943-021-01376-w","journal-title":"Mol Cancer"},{"key":"664_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3109\/07357907.2013.789905","volume":"31","author":"SH Huang","year":"2013","unstructured":"Huang SH, Li Y, Zhang J et al (2013) Epidermal growth factor receptor-containing exosomes induce tumor-specific regulatory T cells. Cancer Invest 31:330\u2013335. https:\/\/doi.org\/10.3109\/07357907.2013.789905","journal-title":"Cancer Invest"},{"key":"664_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2020.00276","volume":"11","author":"V Janelle","year":"2020","unstructured":"Janelle V, Rulleau C, Del Testa S et al (2020) T-cell immunotherapies targeting histocompatibility and tumor antigens in hematological malignancies. Front Immunol 11:276. https:\/\/doi.org\/10.3389\/fimmu.2020.00276","journal-title":"Front Immunol"},{"key":"664_CR24","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s10616-016-9952-7","volume":"68","author":"KB Johnsen","year":"2016","unstructured":"Johnsen KB, Gudbergsson JM, Skov MN et al (2016) Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes. Cytotechnology 68:2125\u20132138. https:\/\/doi.org\/10.1007\/s10616-016-9952-7","journal-title":"Cytotechnology"},{"key":"664_CR25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/ijms21030727","volume":"21","author":"HS Joo","year":"2020","unstructured":"Joo HS, Suh JH, Lee HJ et al (2020) Current knowledge and future perspectives on mesenchymal stem cell-derived exosomes as a new therapeutic agent. Int J Mol Sci 21:727. https:\/\/doi.org\/10.3390\/ijms21030727","journal-title":"Int J Mol Sci"},{"key":"664_CR26","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367:eaau6977. https:\/\/doi.org\/10.1126\/science.aau6977","journal-title":"Science"},{"key":"664_CR27","doi-asserted-by":"publisher","first-page":"101042831769836","DOI":"10.1177\/1010428317698365","volume":"39","author":"S Khorrami","year":"2017","unstructured":"Khorrami S, Zavaran Hosseini A, Mowla SJ et al (2017) MicroRNA-146a induces immune suppression and drug-resistant colorectal cancer cells. Tumour Biol 39:1010428317698365. https:\/\/doi.org\/10.1177\/1010428317698365","journal-title":"Tumour Biol"},{"key":"664_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/cells8040307","volume":"8","author":"JH Kim","year":"2019","unstructured":"Kim JH (2019) Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells 8:307. https:\/\/doi.org\/10.3390\/cells8040307","journal-title":"Cells"},{"key":"664_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/febs.15558","volume":"288","author":"FG Kugeratski","year":"2021","unstructured":"Kugeratski FG, Kalluri R (2021) Exosomes as mediators of immune regulation and immunotherapy in cancer. FEBS J 288:10\u201335. https:\/\/doi.org\/10.1111\/febs.15558","journal-title":"FEBS J"},{"key":"664_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.actbio.2021.04.026","volume":"128","author":"ES Lee","year":"2021","unstructured":"Lee ES, Sul JH, Shin JM (2021) Reactive oxygen species-responsive dendritic cell-derived exosomes for rheumatoid arthritis. Acta Biomater 128:462\u2013473. https:\/\/doi.org\/10.1016\/j.actbio.2021.04.026","journal-title":"Acta Biomater"},{"key":"664_CR31","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.4049\/jimmunol.1103505","volume":"188","author":"Y Liu","year":"2012","unstructured":"Liu Y, Lai L, Chen Q et al (2012) MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. J Immunol 188:5500\u20135510. https:\/\/doi.org\/10.4049\/jimmunol.1103505","journal-title":"J Immunol"},{"key":"664_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41420-021-00534-9","volume":"7","author":"J Lu","year":"2021","unstructured":"Lu J, Wang W, Li P et al (2021) MiR-146a regulates regulatory T cells to suppress heart transplant rejection in mice. Cell Death Discov 7:165. https:\/\/doi.org\/10.1038\/s41420-021-00534-9","journal-title":"Cell Death Discov"},{"key":"664_CR33","doi-asserted-by":"publisher","first-page":"590121","DOI":"10.3389\/fimmu.2020.590121","volume":"11","author":"JJ L\u00fchr","year":"2020","unstructured":"L\u00fchr JJ, Alex N, Amon L et al (2020) Maturation of monocyte-derived DCs leads to increased cellular stiffness, higher membrane fluidity, and changed lipid composition. Front Immunol 11:590121. https:\/\/doi.org\/10.3389\/fimmu.2020.590121","journal-title":"Front Immunol"},{"key":"664_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1158\/0008-5472.CAN-18-1397","volume":"79","author":"J Mastroianni","year":"2019","unstructured":"Mastroianni J, Stickel N, Andrlova H et al (2019) miR-146a controls immune response in the melanoma microenvironment. Cancer Res 79:183\u2013195. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1397","journal-title":"Cancer Res"},{"key":"664_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1600-6143.2005.01197.x","volume":"6","author":"AE Morelli","year":"2006","unstructured":"Morelli AE (2006) The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation. Am J Transplant 6:254\u2013261. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01197.x","journal-title":"Am J Transplant"},{"key":"664_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/mt.2012.180","volume":"21","author":"S Ohno","year":"2013","unstructured":"Ohno S, Takanashi M, Sudo K et al (2013) Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 21:185\u2013191. https:\/\/doi.org\/10.1038\/mt.2012.180","journal-title":"Mol Ther"},{"key":"664_CR37","doi-asserted-by":"publisher","first-page":"708765","DOI":"10.3389\/fonc.2021.708765","volume":"11","author":"K Otmani","year":"2021","unstructured":"Otmani K, Lewalle P (2021) Tumor suppressor miRNA in cancer cells and the tumor microenvironment: mechanism of deregulation and clinical implications. Front Oncol 11:708765. https:\/\/doi.org\/10.3389\/fonc.2021.708765","journal-title":"Front Oncol"},{"key":"664_CR38","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/j.1600-6143.2006.01344.x","volume":"6","author":"H P\u00eache","year":"2006","unstructured":"P\u00eache H, Renaudin K, Beriou G et al (2006) Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model. Am J Transplant 6:1541\u20131550. https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01344.x","journal-title":"Am J Transplant"},{"key":"664_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ (2019) Exosomes. Annu Rev Biochem 88:487\u2013514. https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111902","journal-title":"Annu Rev Biochem"},{"key":"664_CR40","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng Y, Croce CM (2016) The role of MicroRNAs in human cancer. Signal Transduct Target Ther 1:15004. https:\/\/doi.org\/10.1038\/sigtrans.2015.4","journal-title":"Signal Transduct Target Ther"},{"key":"664_CR41","doi-asserted-by":"publisher","first-page":"667834","DOI":"10.3389\/fimmu.2021.667834","volume":"12","author":"MH Ravindranath","year":"2021","unstructured":"Ravindranath MH, El Hilali F, Filippone EJ (2021) The impact of inflammation on the immune responses to transplantation: tolerance or rejection? Front Immunol 12:667834. https:\/\/doi.org\/10.3389\/fimmu.2021.667834","journal-title":"Front Immunol"},{"key":"664_CR42","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1021\/acsnano.9b01004","volume":"13","author":"M Riazifar","year":"2019","unstructured":"Riazifar M, Mohammadi MR, Pone EJ et al (2019) Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS Nano 13:6670\u20136688. https:\/\/doi.org\/10.1021\/acsnano.9b01004","journal-title":"ACS Nano"},{"key":"664_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri3622","volume":"14","author":"PD Robbins","year":"2014","unstructured":"Robbins PD, Morelli AE (2014) Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 14:195\u2013208. https:\/\/doi.org\/10.1038\/nri3622","journal-title":"Nat Rev Immunol"},{"key":"664_CR44","doi-asserted-by":"publisher","first-page":"9797","DOI":"10.3390\/ijms22189797","volume":"22","author":"SC Rodrigues","year":"2021","unstructured":"Rodrigues SC, Cardoso RMS, Freire PC et al (2021) Immunomodulatory properties of umbilical cord blood-derived small extracellular vesicles and their therapeutic potential for inflammatory skin disorders. Int J Mol Sci 22:9797. https:\/\/doi.org\/10.3390\/ijms22189797","journal-title":"Int J Mol Sci"},{"key":"664_CR45","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3389\/fimmu.2014.00578","volume":"5","author":"R Saba","year":"2014","unstructured":"Saba R, Sorensen DL, Booth SA (2014) MicroRNA-146a: A dominant, negative regulator of the innate immune response. Front Immunol 5:578. https:\/\/doi.org\/10.3389\/fimmu.2014.00578","journal-title":"Front Immunol"},{"key":"664_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fimmu.2018.00455","volume":"9","author":"S Sch\u00fclke","year":"2018","unstructured":"Sch\u00fclke S (2018) Induction of interleukin-10 producing dendritic cells as a tool to suppress allergen-specific T helper 2 responses. Front Immunol 9:455. https:\/\/doi.org\/10.3389\/fimmu.2018.00455","journal-title":"Front Immunol"},{"key":"664_CR47","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3389\/fimmu.2017.01062","volume":"8","author":"JB Self-Fordham","year":"2017","unstructured":"Self-Fordham JB, Naqvi AR, Uttamani JR et al (2017) MicroRNA: dynamic regulators of macrophage polarization and plasticity. Front Immunol 8:1062. https:\/\/doi.org\/10.3389\/fimmu.2017.01062","journal-title":"Front Immunol"},{"key":"664_CR48","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1002\/jcp.29601","volume":"235","author":"M Shahir","year":"2020","unstructured":"Shahir M, Mahmoud Hashemi S, Asadirad A et al (2020) Effect of mesenchymal stem cell-derived exosomes on the induction of mouse tolerogenic dendritic cells. J Cell Physiol 235:7043\u20137055. https:\/\/doi.org\/10.1002\/jcp.29601","journal-title":"J Cell Physiol"},{"key":"664_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bcmd.2005.04.004","volume":"35","author":"J Sprent","year":"2005","unstructured":"Sprent J (2005) Direct stimulation of na\u00efve T cells by antigen-presenting cell vesicles. Blood Cells Mol Dis 35:17\u201320. https:\/\/doi.org\/10.1016\/j.bcmd.2005.04.004","journal-title":"Blood Cells Mol Dis"},{"key":"664_CR50","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","volume":"9","author":"RM Steinman","year":"1991","unstructured":"Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271\u2013296. https:\/\/doi.org\/10.1146\/annurev.iy.09.040191.001415","journal-title":"Annu Rev Immunol"},{"key":"664_CR51","doi-asserted-by":"publisher","first-page":"259689","DOI":"10.1155\/2014\/259689","volume":"2014","author":"Z Stumpfova","year":"2014","unstructured":"Stumpfova Z, Hezova R, Meli AC et al (2014) MicroRNA profiling of activated and tolerogenic human dendritic cells. Mediators Inflamm 2014:259689. https:\/\/doi.org\/10.1155\/2014\/259689","journal-title":"Mediators Inflamm"},{"key":"664_CR52","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.celrep.2019.12.081","volume":"30","author":"JA Sullivan","year":"2020","unstructured":"Sullivan JA, Tomita Y, Jankowska-Gan E et al (2020) Treg-cell-derived IL-35-coated extracellular vesicles promote infectious tolerance. Cell Rep 30:1039-1051.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.081","journal-title":"Cell Rep"},{"key":"664_CR53","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1172\/JCI123839","volume":"129","author":"Y Sun","year":"2019","unstructured":"Sun Y, Oravecz-Wilson K, Bridges S et al (2019) miR-142 controls metabolic reprogramming that regulates dendritic cell activation. J Clin Invest 129:2029\u20132042. https:\/\/doi.org\/10.1172\/JCI123839","journal-title":"J Clin Invest"},{"key":"664_CR54","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD, Boldin MP, Chang KJ et al (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103:12481\u201312486. https:\/\/doi.org\/10.1073\/pnas.0605298103","journal-title":"Proc Natl Acad Sci USA"},{"key":"664_CR55","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fimmu.2020.00221","volume":"11","author":"A Taghikhani","year":"2020","unstructured":"Taghikhani A, Farzaneh F, Sharifzad F et al (2020) Engineered tumor-derived extracellular vesicles: potentials in cancer immunotherapy. Front Immunol 11:221. https:\/\/doi.org\/10.3389\/fimmu.2020.00221","journal-title":"Front Immunol"},{"key":"664_CR56","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/08820139.2019.1708385","volume":"49","author":"H Tang","year":"2020","unstructured":"Tang H, Lai Y, Zheng J et al (2020) MiR-146a promotes tolerogenic properties of dendritic cells and through targeting Notch1 signaling. Immunol Invest 49:555\u2013570. https:\/\/doi.org\/10.1080\/08820139.2019.1708385","journal-title":"Immunol Invest"},{"key":"664_CR57","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ncrna3030022","volume":"3","author":"U Testa","year":"2017","unstructured":"Testa U, Pelosi E, Castelli G et al (2017) miR-146 and miR-155: Two key modulators of immune response and tumor development. Noncoding RNA 3:22. https:\/\/doi.org\/10.3390\/ncrna3030022","journal-title":"Noncoding RNA"},{"key":"664_CR58","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi Y, Shitara K, Nishikawa H (2019) Regulatory T cells in cancer immunosuppression - implications for anticancer therapy. Nat Rev Clin Oncol 16:356\u2013371. https:\/\/doi.org\/10.1038\/s41571-019-0175-7","journal-title":"Nat Rev Clin Oncol"},{"key":"664_CR59","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1038\/s41598-018-24531-8","volume":"8","author":"SL Tung","year":"2018","unstructured":"Tung SL, Boardman DA, Sen M et al (2018) Regulatory T cell-derived extracellular vesicles modify dendritic cell function. Sci Rep 8:6065. https:\/\/doi.org\/10.1038\/s41598-018-24531-8","journal-title":"Sci Rep"},{"key":"664_CR60","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1093\/nar\/gks463","volume":"40","author":"J Wahlgren","year":"2012","unstructured":"Wahlgren J, De Karlson LT, Brisslert M et al (2012) Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res 40:e130. https:\/\/doi.org\/10.1093\/nar\/gks463","journal-title":"Nucleic Acids Res"},{"key":"664_CR61","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ (2020) A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol 20:651\u2013668. https:\/\/doi.org\/10.1038\/s41577-020-0306-5","journal-title":"Nat Rev Immunol"},{"key":"664_CR62","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.4049\/jimmunol.0900970","volume":"183","author":"EU Wieckowski","year":"2009","unstructured":"Wieckowski EU, Visus C, Szajnik M et al (2009) Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J Immunol 183:3720\u20133730. https:\/\/doi.org\/10.4049\/jimmunol.0900970","journal-title":"J Immunol"},{"key":"664_CR63","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00281-018-0679-8","volume":"40","author":"F Zeng","year":"2018","unstructured":"Zeng F, Morelli AE (2018) Extracellular vesicle-mediated MHC cross-dressing in immune homeostasis, transplantation, infectious diseases, and cancer. Semin Immunopathol 40:477\u2013490. https:\/\/doi.org\/10.1007\/s00281-018-0679-8","journal-title":"Semin Immunopathol"},{"key":"664_CR64","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3389\/fimmu.2014.00518","volume":"5","author":"B Zhang","year":"2014","unstructured":"Zhang B, Yin Y, Lai RC et al (2014) Immunotherapeutic potential of extracellular vesicles. Front Immunol 5:518. https:\/\/doi.org\/10.3389\/fimmu.2014.00518","journal-title":"Front Immunol"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-022-00664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00005-022-00664-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-022-00664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:55Z","timestamp":1704228595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00005-022-00664-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1007\/s00005-022-00664-7","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"28 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"27"}}